Ridgeback Biotherapeutics Archives

MSD starts enrollment for Phase 3 clinical trial of molnupiravir

MSD in the Philippines (tradename of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE: MRK) has announced the initiation of the Phase 3 portion...

Oral treatment promising, says German Merck

German pharmaceutical giant Merck and a US partner reported promising results in trials of a drug administered orally to fight COVID-19, saying it helps...

Oral COVID treatment yields promising trial data: drugmakers

German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight COVID-19, saying it...

Tag: Ridgeback Biotherapeutics

MSD starts enrollment for Phase 3 clinical trial of molnupiravir

Oral treatment promising, says German Merck

Oral COVID treatment yields promising trial data: drugmakers

News

Opinion

Business

Sports

Showbiz

Lifestyle

Tech

On the Road

Gallery

Spotlight

Real Estate

Binondo

Transport

Pets

Pop.Life

Environment and Sustainability

Advertise with us | Privacy Policy